Roderich Schwarz, MD, PhD

Professor
Endowed Title: Mark and Jane Gibson Distinguished Professorship in Cancer Research
Surgery

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

roderich.schwarz@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Biography

Dr. Roderich Schwarz joined the Department of Surgery at the UT Southwestern Medical School and the Simmons Comprehensive Cancer Center in the middle of 2007, to serve as Professor of Surgery and Chairman of the Division of Surgical Oncology. A native of Germany, he completed his medical training at the Medical School in Hannover, Germany, in 1984, and presented his dissertation with a thesis in experimental hepatopathology in 1985. Until 1989, he was a postdoctoral research fellow at the Pittsburgh Cancer Institute in Pittsburgh, PA, and subsequently underwent residency training in General Surgery in the Department of Surgery at the University of Pittsburgh. In 1994, he started a two-year fellowship training in Surgical Oncology at Memorial Sloan-Kettering Cancer Center in New York, where he has received specialty training for gastrointestinal cancer with Drs. Murray F. Brennan, Alfred M. Cohen, and Leslie H. Blumgart. From 1996 to 2001, he served as Section Head of Upper Gastrointestinal and Pancreatobiliary Surgery at the City of Hope Cancer Center in Los Angeles, California. Subsequently, he led the Pancreatic Cancer Program at the Cancer Institute of New Jersey and Robert Wood Johnson Medical School in New Brunswick, NJ, from 2001 to 2007. Dr. Schwarz has a special interest in upper gastrointestinal malignancies, including pancreatic, hepatobiliary, and gastric cancer. He has presented numerous talks at national and international meetings, and has authored more than eighty peer reviewed journal articles and several book chapters. His research interests focus on experimental combination therapy for pancreatic and gastric cancer, novel locoregional therapies for liver and bile duct lesions, and minimizing morbidity after major visceral resections. Dr. Schwarz has taken an active role in the design and implementation of experimental multidisciplinary treatment protocols for gastrointestinal cancer at UTSW. Of major interest are: 1. adjuvant combination treatment strategies that incorporate molecular-targeted drugs for growth inhibition and antiangiogenesis with conventional cytotoxic therapy; 2. intraperitoneal treatment with or without surgical cytoreduction; 3. regional intrahepatic chemotherapy after resection / radiofrequency ablation of hepatic metastases. Dr. Schwarz seeks to create a cooperative and productive relationship with physicians who diagnose and treat gastrointestinal cancer. He is available for clinical consultations or direct physician contact at any time.

Education

FellowshipMemorial Sloan Kettering Cancer Institute, Surgical Oncology (1996)
ResidencyUniversity of Pittsburgh Medical Center Medical Education, General Surgery (1994)
Medical SchoolMedical School of Hannover L.S. Germany (1984)

Publications

Featured
Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Schwarz, R.E., Smith, D.D. , Ann. Surg. Oncol. , February 2007; (14(2)):317-328

Featured
Visceral organ resections combined with synchronous major hepatectomy: examples of safety and feasibility.

Schwarz, R.E. , HPB J. Internat. Hepato Pancreato Biliary Assoc. , 2003; (5(1)):27-32

Featured
The impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis.

Schwarz, R.E., Smith, D.D., Keny, H., Ikle, D.N., Shibata, S.I., Chu, D.Z.J., Pezner, R.D. , Am. J. Clin. Oncol. , 2003; (26 (1)):16-21

Featured
Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy.

Schwarz, R.E., Zagala-Nevarez, K. , Ann. Surg. Oncol. , 2002; (9(4)):394-400

Featured
The impact of splenectomy on outcome after resection of pancreatic adenocarcinoma.

Schwarz, R.E., Harrison, L.E., Conlon, K.C., Klimstra, D.S., Brennan, M.F. , J. Am. Coll. Surg. , 1999; (188):516-521

Factors influencing change of preoperative treatment intent in patients with gastrointestinal cancer.

Schwarz, R.E. , World J. Surg. Oncol. , March 2007; (5(1)):32

Estrogen receptor beta / alpha ratio predicts pancreatic cancer cell response to estrogens and phytoestrogens.

Konduri, S., Schwarz, R.E. , J. Surg. Res. , June 2007; (140(1)):55-66

Factors influencing perioperative blood transfusions in patients with gastrointestinal cancer.

Verma, V., Schwarz, R.E. , J. Surg. Res. , July 2007; (141 (1)):97-104

Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data.

Schwarz, R.E., Smith, D.D. , J. Gastrointest. Surg. , February 2007; (11(2)):158-65

Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Schwarz, R.E., Smith, D.D. , J. Gastrointest. Surgery , 2007; ((in press))

Honors/Awards

UMDNJ Robert Wood Johnson Medical School

Residents’ Theodor Kocher Teaching Award (2006)

Japan Surgical Society

Traveller’s Grant Award to the 101st Annual Congress, Sendai, Japan (2001)

NIH-K12 Fellow Award

City of Hope National Medical Center (2001)

Society of Surgical Oncology

48th Annual Cancer Symposium: Poster Presentation Award (1995)

Deutsche Forschungsgemeinschaft

International Research Training Award (1989)

Professional Associations/Affiliations

American Association for Cancer Research

American College of Surgeons (FACS)

Society of Surgery of the Alimentary Tract

Society of Surgical Oncology

Society of University Surgeons